This Announcement Is Not A Procurement Announcement Or A Request For Quotation. With This Request For Information, Hus Starts The Market Dialogue For The Planned Acquisition. The Request For Information Does Not Obligate The Procurement Unit To Carry Out The Actual Procurement Procedure. All The Information Presented In This Information Request Is Preliminary And Does Not Bind The Procurement Entity In The Execution Of The Procurement Or In The Later Stages Of The Project. Reporters Are Not Compensated For Responding To A Request For Information. The Subject Of The Planned Acquisition Is The Development And Production Of A Stool Capsule Machine (Medical Device) With The Help Of An Innovation Partnership. Innovation Partnership Has Been Chosen As The Procurement Procedure, Because There Is No Solution On The Market That Meets The Procurement Need. The Goal Of The Acquisition Is To Renew And Enhance The Current Treatment Process By Utilizing New Technology. A Stool Transplant Performed In Conjunction With A Colonoscopy Is Relatively Expensive And Burdensome For The Patient. If Implemented With Capsules, The Treatment Would Be Significantly Easier For The Patient And The Health Care System Than If Implemented Through Observation. Fecal Transplants Are Performed In Finland For Approximately 100 Patients Each Year. The Most Common Indication For Stool Transplantation Is Diarrhea Associated With Antibiotic Treatment, I.E. C. Difficile Infection. With The Capsules, It Would Be Possible To Treat 1,000-2,000 Patients With A Recurrence Of C. Difficile Infection. C. Difficile Infection Is Still Common, And Is Often A Serious Illness Requiring Hospitalization, Which Is Also Associated With Mortality. New Infections Are Diagnosed Annually In Finland In Approximately 3,200-4,100 Patients, And Approximately 25% Of Infections Recur After Standard Antibiotic Treatment. Recurrence After A Faeces Transplant Is Rare, I.E. Only About 5% Of Transplant Recipients Have A New Infection. Recurrent C. Difficile Infection Is A Disease That Burdens Healthcare Globally, And There Is A Wide Interest In Solving It. In The Future, It Is Likely That Stool Transplantation Can Also Be Used For The Treatment Of Other Diseases (E.G. For The Eradication Of Multiresistant Bacteria). Huss Preliminary Plan Is To Establish An Innovation Partnership To Manufacture The Device. The Innovation Partnership Combines A Research And Development Service And Procurement For The Implementation Of The Resulting Prototype. It Is Hoped That The Device Created As A Result Of The Innovation Partnership Will Have Potential For Scaling Also From The Point Of View Of Wider Adoption, Which Would Open Up Opportunities For The Supplier To Take The Solution To New Markets. Innovation Partnership Is A Multi-Stage Procedure. The Procedure Starts With The Publication Of The Procurement Notice. The Development Phase Is Supposed To Start With The Selected Supplier(S) After The Summer Holidays In 2026. According To The Preliminary Goal And Plan, The Stool Capsule Machine Is Supposed To Be In Use In 2027. A Contract Of One Or More Years Will Be Concluded With The Selected Supplier(S). The Purpose Of The Market Dialogue Is To Hold A Discussion With Service Providers As Widely As Possible. All Parties With Experience In The Technology Required For Procurement Or Other Such Expertise That Would Contribute To The Achievement Of The Goal Are Invited To Participate In The Market Dialogue. We Ask All Service Providers Interested In Procurement To Register By Email. Registrations Are Sent To:
[email protected] And
[email protected]. Registration Takes Place By Providing Contact Information. Registrations Are Requested As Soon As Possible, By 09.03.2026 At 11 A.M. However, You Can Also Register For The Market Dialogue After The Given Deadline (Until March 31, 2026). Along With The Registration, You Can Provide References And Descriptions Of Your Business If You Wish (Optional). Please Let Us Know If, In Your Opinion, The Information You Provide Contains Business Secrets Or Other Confidential Information. Please Identify And Mark The Information Clearly. The Purpose Of This Market Survey Is To Increase The Purchasing Units Market Knowledge And To Provide Information On Planned Purchases To The Market. The Goal Of The Market Dialogue Is To Obtain Information That Can Be Used To Plan Procurement As Efficiently As Possible. In The Later Stages Of The Market Dialogue, The Procurement Unit Can, For Example, Send Drafts Of Tender Documents To Those Registered For Comment And Hold Discussions With Suppliers. The Language Used In The Market Dialogue Is Finnish. The Results Obtained In The Market Dialogue Can Be Used To Prepare Procurement Documents. Responding To The Market Dialogue Does Not Bind The Potential Supplier, And Is Not A Prerequisite For Later Participation In Actual Tenders. Responding Or Not Responding To The Market Dialogue Does Not Affect The Potential Suppliers Position In The Actual Tenders.
